Cadence Bank Abb Vie Inc. Transaction History
Cadence Bank
- $1.46 Billion
- Q4 2024
A detailed history of Cadence Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Cadence Bank holds 101,290 shares of ABBV stock, worth $20.3 Million. This represents 1.23% of its overall portfolio holdings.
Number of Shares
101,290
Previous 100,082
1.21%
Holding current value
$20.3 Million
Previous $19.8 Million
8.93%
% of portfolio
1.23%
Previous 1.37%
Shares
29 transactions
Others Institutions Holding ABBV
# of Institutions
4,092Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$34.8 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.4 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.97 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $355B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...